Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Deep Brain Stimulation for Severe Self-Injurious Behaviour in Children

NCT: NCT06529380 · RECRUITING

NCT IDNCT06529380
StatusRECRUITING
Start Date2024-09-11
Completion2026-12-31

Brief Summary

Deep Brain Stimulation for the Treatment of Severe Refractory Self-Injurious Behaviour in Children with Autism Spectrum Disorder: A Randomized Trial To evaluate the effectiveness of deep brain stimulation (DBS) of the nucleus accumbens for the treatment of severe refractory, repetitive self-injurious behavior (SIB) in children with Autism Spectrum Disorder. Secondary objectives are to examine the effects of DBS on subtypes of SIB through functional analysis.

Frequently Asked Questions

What is Deep Brain Stimulation for Severe Self-Injurious Behaviour in Children?

Deep Brain Stimulation for Severe Self-Injurious Behaviour in Children is a clinical trial registered under NCT06529380. Current status: RECRUITING.

What is the status of NCT06529380?

The current status of NCT06529380 (Deep Brain Stimulation for Severe Self-Injurious Behaviour in Children) is: RECRUITING.

When did Deep Brain Stimulation for Severe Self-Injurious Behaviour in Children start?

Deep Brain Stimulation for Severe Self-Injurious Behaviour in Children started on 2024-09-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.